When we analyzed B cell populations, we observed a reduction in absolute B cell count in non- treated patients with SSc as compared to controls, moreover a reduction in the frequency of memory B cells (as a percentage of all CD19) was observed in the whole SSc group in comparison to healthy subjects. Here, CD19 is linked to systemic sclerosis.